HK Stock MarketDetailed Quotes
02315 BIOCYTOGEN-B
- 5.840
- +0.080+1.39%
Market Closed Nov 29 16:08 CST
2.33BMarket Cap-8729P/E (TTM)
6.000High5.810Low110.50KVolume5.850Open5.760Pre Close650.75KTurnover0.10%Turnover RatioLossP/E (Static)399.40MShares12.80052wk High2.88P/B646.97MFloat Cap5.60052wk Low--Dividend TTM110.78MShs Float28.800Historical High--Dividend LFY3.30%Amplitude5.600Historical Low5.889Avg Price500Lot Size--Div YieldTTM--Div Yield LFY
BIOCYTOGEN-B Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | |||||||||
| Earning before tax | ---- | 36.78%-380.16M | ---- | -10.21%-601.35M | ---- | -14.46%-545.64M | ---- | -55.57%-476.69M | ---306.41M |
| Profit adjustment | |||||||||
| Attributable subsidiary (profit) loss | ---- | -32.11%10.03M | ---- | 3,574.13%14.77M | ---- | 562.07%402K | ---- | ---87K | ---- |
| Impairment and provisions: | ---- | 184.97%13.7M | ---- | -2.30%4.81M | ---- | 19.00%4.92M | ---- | 19.57%4.14M | --3.46M |
| -Impairmen of inventory (reversal) | ---- | 178.18%9.42M | ---- | 87.44%3.39M | ---- | -31.14%1.81M | ---- | -12.82%2.62M | --3.01M |
| -Impairment of trade receivables (reversal) | ---- | 201.13%4.28M | ---- | -54.35%1.42M | ---- | 106.02%3.12M | ---- | 236.75%1.51M | --449K |
| Revaluation surplus: | ---- | 75.80%-5.03M | ---- | -83.57%-20.78M | ---- | 48.86%-11.32M | ---- | -2,800.79%-22.13M | ---763K |
| -Derivative financial instruments fair value (increase) | ---- | ---- | ---- | --2.41M | ---- | ---- | ---- | ---- | ---- |
| -Other fair value changes | ---- | 78.32%-5.03M | ---- | -104.89%-23.19M | ---- | 48.86%-11.32M | ---- | -2,800.79%-22.13M | ---763K |
| Asset sale loss (gain): | ---- | 92.77%-1.83M | ---- | -2,404.45%-25.35M | ---- | 50.95%-1.01M | ---- | -1,922.55%-2.06M | ---102K |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---25.43M | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -2,334.15%-1.83M | ---- | 121.30%82K | ---- | -132.06%-385K | ---- | 4,904.17%1.2M | --24K |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---- | 80.79%-627K | ---- | -2,490.48%-3.26M | ---126K |
| Depreciation and amortization: | ---- | 4.79%182.45M | ---- | 35.91%174.1M | ---- | 195.38%128.1M | ---- | 52.45%43.37M | --28.45M |
| -Amortization of intangible assets | ---- | 150.67%7.68M | ---- | 89.67%3.07M | ---- | 84.90%1.62M | ---- | 14.85%874K | --761K |
| Financial expense | ---- | 77.85%99.84M | ---- | 42.39%56.14M | ---- | 74.93%39.43M | ---- | 187.21%22.54M | --7.85M |
| Exchange Loss (gain) | ---- | 57.64%-7.02M | ---- | -1,032.88%-16.57M | ---- | -73.05%1.78M | ---- | 778.68%6.59M | ---971K |
| Special items | ---- | 38.74%21.25M | ---- | -44.82%15.31M | ---- | -87.84%27.75M | ---- | 49.79%228.27M | --152.39M |
| Operating profit before the change of operating capital | ---- | 83.26%-66.77M | ---- | -12.18%-398.91M | ---- | -81.36%-355.6M | ---- | -68.89%-196.08M | ---116.1M |
| Change of operating capital | |||||||||
| Inventory (increase) decrease | ---- | 159.28%3.79M | ---- | 78.64%-6.4M | ---- | -466.84%-29.96M | ---- | -13,453.85%-5.29M | ---39K |
| Accounts receivable (increase)decrease | ---- | -749.44%-39.02M | ---- | 87.19%-4.59M | ---- | -10.75%-35.86M | ---- | -1,036.18%-32.38M | ---2.85M |
| Accounts payable increase (decrease) | ---- | -100.02%-21K | ---- | 59.31%88.27M | ---- | 198.79%55.41M | ---- | 264.75%18.54M | --5.08M |
| prepayments (increase)decrease | ---- | -48.37%16.36M | ---- | 363.41%31.69M | ---- | 25.33%-12.03M | ---- | 8.24%-16.11M | ---17.56M |
| Special items for working capital changes | ---- | 177.09%9.65M | ---- | -201.96%-12.51M | ---- | 104.65%12.27M | ---- | -93.64%6M | --94.31M |
| Cash from business operations | 286.03%32.68M | 74.94%-76.01M | 84.19%-17.57M | 17.09%-303.27M | 28.98%-111.16M | -62.34%-365.78M | ---156.52M | -506.43%-225.31M | ---37.15M |
| Other taxs | ---3.08M | 20.40%-640K | ---- | ---804K | ---- | ---- | ---- | ---- | ---- |
| Special items of business | ---- | ---- | ---- | --804K | ---- | ---- | ---- | ---- | ---- |
| Net cash from operations | 268.52%29.61M | 74.73%-76.65M | 84.19%-17.57M | 17.09%-303.27M | 28.98%-111.16M | -62.34%-365.78M | ---156.52M | -506.43%-225.31M | ---37.15M |
| Cash flow from investment activities | |||||||||
| Sale of fixed assets | 19.83%278K | 1,511.01%26.34M | 172.94%232K | -65.63%1.64M | -93.06%85K | 10,471.11%4.76M | --1.22M | -71.15%45K | --156K |
| Purchase of fixed assets | 75.14%-22.43M | 47.30%-126.62M | 33.74%-90.24M | -20.94%-240.27M | -10.65%-136.2M | 32.98%-198.67M | ---123.09M | -93.32%-296.42M | ---153.34M |
| Sale of subsidiaries | ---- | ---- | ---- | ---6.86M | ---6.86M | ---- | ---- | ---- | ---- |
| Recovery of cash from investments | ---- | ---- | ---- | -84.38%101.46M | -39.60%100M | -53.36%649.78M | --165.56M | 2,254.09%1.39B | --59.18M |
| Cash on investment | ---9.81M | ---- | ---- | 98.20%-9.71M | ---- | 57.98%-540M | ---360M | -314.52%-1.29B | ---310M |
| Net cash from investment operations | 64.49%-31.96M | 34.77%-100.28M | -109.48%-90.01M | -82.74%-153.74M | 86.42%-42.97M | 55.29%-84.13M | ---316.31M | 53.42%-188.18M | ---404M |
| Net cash before financing | 97.81%-2.36M | 61.29%-176.92M | 30.20%-107.58M | -1.58%-457M | 67.40%-154.13M | -8.81%-449.91M | ---472.83M | 6.27%-413.49M | ---441.15M |
| Cash flow from financing activities | |||||||||
| New borrowing | 42.50%161.55M | 52.63%319.91M | 98.15%113.37M | --209.6M | --57.22M | ---- | ---- | ---- | ---- |
| Refund | -166.85%-154.24M | -402.96%-150.82M | -1,053.92%-57.8M | ---29.99M | 86.52%-5.01M | ---- | ---37.15M | -688.55%-72.13M | ---9.15M |
| Interest paid - financing | -54.02%-15.37M | -41.66%-24.08M | -173.72%-9.98M | -121.83%-17M | 3.49%-3.65M | -91.24%-7.66M | ---3.78M | -474.07%-4.01M | ---698K |
| Absorb investment income | ---- | ---- | ---- | 67.52%521.06M | ---- | 216.23%311.04M | --291.6M | 31,629.03%98.36M | --310K |
| Issuance expenses and redemption of securities expenses | 81.20%-483K | 53.08%-10.77M | 73.25%-2.57M | 14.36%-22.96M | ---9.6M | ---26.81M | ---- | ---- | ---- |
| Other items of the financing business | 95.60%-381K | -188.60%-149.9M | 42.86%-8.67M | -23.21%-51.94M | ---15.17M | -104.96%-42.15M | ---- | 70.00%850M | --500M |
| Net cash from financing operations | -162.60%-13.47M | -106.44%-37.82M | 79.86%21.51M | 167.59%587.2M | -95.12%11.96M | -74.73%219.44M | --245.3M | 77.39%868.44M | --489.56M |
| Effect of rate | -79.23%2.07M | -75.65%3.47M | 31.72%9.95M | 3,847.63%14.24M | 164.76%7.55M | 90.59%-380K | --2.85M | -349.78%-4.04M | ---898K |
| Net Cash | 81.62%-15.82M | -264.94%-214.74M | 39.46%-86.07M | 156.49%130.2M | 37.52%-142.17M | -150.66%-230.47M | ---227.53M | 839.88%454.95M | --48.41M |
| Begining period cash | -34.59%399.61M | 30.97%610.88M | 30.97%610.88M | -33.11%466.45M | -33.11%466.45M | 183.01%697.29M | --697.29M | 23.89%246.38M | --198.88M |
| Cash at the end | -27.85%385.85M | -34.59%399.61M | 61.16%534.76M | 30.97%610.88M | -29.79%331.83M | -33.11%466.45M | --472.62M | 183.01%697.29M | --246.38M |
| Cash balance analysis | |||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
| Auditor | -- | KPMG | -- | KPMG | -- | KPMG | -- | KPMG | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
% Chg
No Data